{"altmetric_id":231846,"counts":{"readers":{"mendeley":64,"citeulike":0,"connotea":0},"total":{"posts_count":1},"f1000":{"unique_users_count":1,"unique_users":["F1000Prime"],"posts_count":1}},"citation":{"abstract":"Rituximab has been shown to be active in follicular lymphoma (FL), both as monotherapy and in combination with chemotherapy. We conducted a randomized trial comparing mitoxantrone, chlorambucil, and prednisolone (MCP) chemotherapy plus rituximab with MCP alone.","abstract_source":"pubmed","altmetric_jid":"4f6fa5e93cf058f610005a18","doi":"10.1200\/jco.2006.06.4618","first_seen_on":"2011-08-16T05:35:13+00:00","issns":["1527-7755"],"issue":"15","journal":"Journal of Clinical Oncology","last_mentioned_on":1182816000,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17420513"],"pmid":"17420513","pubdate":"2007-05-20T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study.","type":"article","volume":"25","mendeley_url":"http:\/\/www.mendeley.com\/research\/rituximab-added-firstline-mitoxantrone-chlorambucil-prednisolone-chemotherapy-followed-interferon-ma"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":3630293,"mean":4.9302727339889,"rank":2015655,"this_scored_higher_than_pct":25,"this_scored_higher_than":941752,"rank_type":"exact","sample_size":3630293,"percentile":25},"similar_age_3m":{"total_number_of_other_articles":51731,"mean":4.6858190218442,"rank":22043,"this_scored_higher_than_pct":42,"this_scored_higher_than":22047,"rank_type":"exact","sample_size":51731,"percentile":42},"this_journal":{"total_number_of_other_articles":4898,"mean":8.1553069226057,"rank":3352,"this_scored_higher_than_pct":12,"this_scored_higher_than":624,"rank_type":"exact","sample_size":4898,"percentile":12},"similar_age_this_journal_3m":{"total_number_of_other_articles":47,"mean":4.1457391304348,"rank":23,"this_scored_higher_than_pct":19,"this_scored_higher_than":9,"rank_type":"exact","sample_size":47,"percentile":19}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":4,"Librarian":1,"Researcher":14,"Student  > Doctoral Student":10,"Student  > Ph. D. Student":7,"Student  > Postgraduate":6,"Other":8,"Student  > Master":3,"Student  > Bachelor":3,"Lecturer":1,"Lecturer > Senior Lecturer":3,"Professor":3},"by_discipline":{"Medicine and Dentistry":43,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":13,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":4,"Environmental Science":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"mendeley":{"EC":2,"CZ":1,"NL":1,"US":3,"BR":1}}},"posts":{"f1000":[{"title":"Recommended in F1000 Prime","url":"https:\/\/f1000.com\/prime\/1084981","license":"public","citation_ids":[231846],"posted_on":"2007-06-26T00:00:00+00:00","f1000_classes":["confirmation"],"f1000_score":"1"}]}}